Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Evogene Ltd. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $14.15M | $14.15M - $14.15M | -$14.15M | -$0.30 | 1 |
| Dec 2029 | $8.30M | $8.30M - $8.30M | -$8.30M | -$0.40 | 1 |
| Dec 2028 | $4.95M | $4.95M - $4.95M | -$4.95M | -$0.55 | 1 |
| Dec 2027 | $2.60M | $2.60M - $2.60M | -$2.60M | -$0.80 | 1 |
| Dec 2026 | $1.48M | $1.48M - $1.48M | -$1.48M | -$1.70 | 1 |
| Dec 2025 | $3.92M | $3.92M - $3.92M | -$3.92M | -$0.62 | 1 |
| Dec 2024 | $10.53M | $10.53M - $10.53M | -$10.53M | -$4.115 | 1 |
| Dec 2023 | $9.45M | $9.45M - $9.45M | -$9.45M | $0.00 | 1 |
| Dec 2022 | $1.20M | $1.20M - $1.20M | -$19.30M | -$7.60 | 1 |
| Dec 2021 | $624.0K | $624.0K - $624.0K | -$624.0K | -$7.167 | 1 |
| Dec 2019 | $80.00M | $80.00M - $80.00M | -$80.00M | $10.00 | 1 |
| Dec 2018 | $9.20M | $9.20M - $9.20M | -$9.20M | -$7.50 | 6 |